Detection of interleukin-2 is not useful for distinguishing between latent and active tuberculosis in clinical practice: a prospective cohort study

Authors :: Santin M
Morandeira-Rego F
Alcaide F
Rabuñal R
Anibarro L
Agüero-Balbín R
Casas X
Pérez-Escolano E
Navarro MD
Sánchez F
Coira-Nieto A
Trigo-Daporta M
Martinez-Meñaca A
Gonzalez-Cuevas MA
López-Prieto MD
Domínguez-Castellano Á
Jové N
Source :: CLINICAL MICROBIOLOGY AND INFECTION, r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, instname, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu
Publication Year :: 2016
Publisher :: WILEY-BLACKWELL, 2016.
Abstract: Previous reports have identified interleukin-2 (IL-2), quantified in the supernatants of QuantiFERON(®)-TB Gold In-tube (QFT) after 72 h of incubation, as a potential biomarker for distinguishing between latent and active tuberculosis (TB). However, its validity has not been tested in an appropriate clinical cohort.

Subjects :: bacterial infections and mycoses
Active tuberculosis, Interferon-?, Interleukin-2, Latent tuberculosis infection, QuantiFERON

ISSN :: 1198743X
Database :: OpenAIRE
Journal :: CLINICAL MICROBIOLOGY AND INFECTION, r-FSJD. Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, instname, r-FSJD: Repositorio Institucional de Producción Científica de la Fundació Sant Joan de Déu, Fundació Sant Joan de Déu
Accession number :: edsair.dedup.wf.001..56b473b45388832a9c59ba3370c56d50

Tools